In March of this year, Wegovy was approved for overweight or obese patients with cardiovascular disease
This rapid glucose lowering can also induce hypoxia, which may modulate the effect of GLP-1 RAs on retinal VEGF expression [100]
Clinical Results You Can See In clinical studies, A.G.E
Side effects in long term trials Side effects in long term trials Though GLP-1 receptor agonist drugs like Wegovy and Ozempic may seem new to the public, these drugs have been tested in patients for decades
Acute & Chronic Inflammation There has been growing interest in GLP-1 microdosing for managing both acute and chronic inflammation, particularly in conditions such as PCOS, cardiovascular disease, and even sports performance
Micro-dosing GLP-1s Microdosing GLP-1 medications can be effective for individuals who want to make small adjustments to their weight or maintain their results